Novel & Innovative Therapeutics - Thomas Collet, PhD & Robert Langer, SCD - Bilayer Therapeutics

Learn from Thomas Collet, PhD, Bilayer Therapeutics - President & CEO; and Robert Langer, SCD
Bilayer Therapeutics - Director & Scientific Advisor, MIT, about how the company is creating first-in-class therapies for gastrointestinal disease and metabolic disorders. 

 

Bilayer Therapeutics

https://bilayer-therapeutics.com

 

Hosted by Steven Saltzstein, CEO, FORCE Family Office: 

https://forcefamilyoffice.com